09 January 2012 Notification of Preliminary Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that it will issue its preliminary results for the year ended 31 December 2011 on Tuesday 13 March 2012.

A meeting for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan Communications, 107 Cheapside, London, EC2V 6DN.

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com

Nominated Adviser:
Nomura Code Securities Limited
Phil Walker / Giles Balleny
Tel: +44 (0) 20 7776 1200

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Jessica Fontaine

Tel: +44 (0) 20 7466 5000

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

distribué par

Ce noodl a été diffusé par Futura Medical plc et initialement mise en ligne sur le site http://www.futuramedical.co.uk. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-09 08:44:12 AM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.